Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Quick Notes: Drug Approvals — July 16, 2024

  • Post author:PacConAdmin
  • Post published:July 16, 2024
  • Post category:Uncategorized

This edition of Quick Notes focuses on congressional urging for approval of MDMA for PTSD and FDA approvals for J&J’s tuberculosis treatment Sirturo, a biosimilar for Eylea, a Stelara biosimilar…

Continue ReadingQuick Notes: Drug Approvals — July 16, 2024

CDRH Reorganizes Offices to Increase Agility, Meet MDUFA Commitments, Priorities

  • Post author:PacConAdmin
  • Post published:July 16, 2024
  • Post category:Uncategorized

New organizational changes in CDRH to strengthen and better position the Center to meet its mission to protect and promote the public health have been announced by the FDA. Source:…

Continue ReadingCDRH Reorganizes Offices to Increase Agility, Meet MDUFA Commitments, Priorities

Baxter Now Removes Life2000 Ventilator From Use, Bausch Removes Eye Injection Kit

  • Post author:PacConAdmin
  • Post published:July 16, 2024
  • Post category:Uncategorized

Baxter is recalling the Life2000 Ventilator System due to the potential for failure of the battery charging dongle, which can prevent the system from charging or only allow for intermittent…

Continue ReadingBaxter Now Removes Life2000 Ventilator From Use, Bausch Removes Eye Injection Kit

House Appropriations Committee Calls for Halt to LDT Rule

  • Post author:PacConAdmin
  • Post published:July 16, 2024
  • Post category:Uncategorized

The FDA should “suspend” its implementation of the laboratory developed test (LDT) rule, the House Appropriations Committee said in its report on its deliberations on the FDA budget for 2025.…

Continue ReadingHouse Appropriations Committee Calls for Halt to LDT Rule

Legislative Update — Week of July 15, 2024

  • Post author:PacConAdmin
  • Post published:July 15, 2024
  • Post category:Uncategorized

As the second session of the 118th Congress begins, FDAnews will track important pending legislation, that has been acted on since Dec. 31, 2023 to keep you updated on laws…

Continue ReadingLegislative Update — Week of July 15, 2024

Warning Letters for Makers of Kids’ Cough Syrup, Eye Drops, Wound Care

  • Post author:PacConAdmin
  • Post published:July 15, 2024
  • Post category:Uncategorized

The FDA has called out three drugmakers for lack of compliance with current good manufacturing practices (cGMP) and marketing unapproved products, among other lapses. Source: Drug Industry Daily

Continue ReadingWarning Letters for Makers of Kids’ Cough Syrup, Eye Drops, Wound Care

AdvaMed Praises CMS Draft Rule Improving Access to Alzheimer’s, Cancer Diagnostics

  • Post author:PacConAdmin
  • Post published:July 15, 2024
  • Post category:Uncategorized

AdvaMed commended CMS for its July 10 proposed rule that includes separate payments for diagnostic radiopharmaceuticals are used to diagnose and treat diseases such as Alzheimer’s and cancer. Source: Drug…

Continue ReadingAdvaMed Praises CMS Draft Rule Improving Access to Alzheimer’s, Cancer Diagnostics

Texas Compounder Sentenced to 2+ Years for Illegal Kickbacks, Money Laundering

  • Post author:PacConAdmin
  • Post published:July 15, 2024
  • Post category:Uncategorized

A Texas pharmaceutical marketer was sentenced to two years and five months in federal prison and ordered to pay over $59 million in restitution for conspiring to defraud the US,…

Continue ReadingTexas Compounder Sentenced to 2+ Years for Illegal Kickbacks, Money Laundering

Regulatory Update — Week of July 8, 2024

  • Post author:PacConAdmin
  • Post published:July 12, 2024
  • Post category:Uncategorized

This week, the FDA published a final guidance on clinical considerations for studies of opioid use devices. Draft guidances were issued for misinformation about drugs and devices, use-related risk analyses…

Continue ReadingRegulatory Update — Week of July 8, 2024

New Class I Hamilton Ventilator Recall, Updated Class I Recalls for Philips, Megadyne

  • Post author:PacConAdmin
  • Post published:July 12, 2024
  • Post category:Uncategorized

Hamilton Medical has issued a recall for correction of the software in one of its ventilators, an issue that could cause the device to fail during procedures, a recall which…

Continue ReadingNew Class I Hamilton Ventilator Recall, Updated Class I Recalls for Philips, Megadyne
  • Go to the previous page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 144
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company